PELLEGRINO, RAFFAELE
 Distribuzione geografica
Continente #
EU - Europa 4.015
NA - Nord America 2.104
AS - Asia 2.025
SA - Sud America 276
Continente sconosciuto - Info sul continente non disponibili 121
AF - Africa 37
OC - Oceania 3
Totale 8.581
Nazione #
RU - Federazione Russa 2.871
US - Stati Uniti d'America 2.025
SG - Singapore 660
IT - Italia 648
CN - Cina 481
VN - Vietnam 249
HK - Hong Kong 234
BR - Brasile 214
IE - Irlanda 121
KR - Corea 106
DE - Germania 101
BD - Bangladesh 87
IN - India 82
GB - Regno Unito 57
JP - Giappone 55
FR - Francia 50
NL - Olanda 44
CA - Canada 29
AT - Austria 27
AR - Argentina 20
FI - Finlandia 20
MX - Messico 17
ES - Italia 13
ZA - Sudafrica 11
EC - Ecuador 10
AZ - Azerbaigian 9
PL - Polonia 9
CR - Costa Rica 8
PK - Pakistan 8
TR - Turchia 8
CO - Colombia 7
IQ - Iraq 7
UA - Ucraina 7
VE - Venezuela 7
EE - Estonia 6
ID - Indonesia 6
PY - Paraguay 6
SE - Svezia 6
MA - Marocco 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
KE - Kenya 4
PH - Filippine 4
SC - Seychelles 4
UZ - Uzbekistan 4
AL - Albania 3
BG - Bulgaria 3
DZ - Algeria 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LU - Lussemburgo 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
UY - Uruguay 3
AU - Australia 2
CI - Costa d'Avorio 2
CL - Cile 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
ET - Etiopia 1
HU - Ungheria 1
IL - Israele 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ML - Mali 1
MM - Myanmar 1
MY - Malesia 1
NO - Norvegia 1
NP - Nepal 1
Totale 8.456
Città #
Moscow 1.012
San Jose 323
Singapore 318
Ashburn 276
Hong Kong 221
Naples 217
Santa Clara 206
Council Bluffs 170
Hefei 134
Dublin 117
Seoul 105
Ho Chi Minh City 87
Beijing 86
New York 75
Los Angeles 66
Milan 65
Hanoi 55
Bengaluru 50
Munich 44
Rome 42
Dallas 36
Amsterdam 29
Orem 26
Boardman 25
North Bergen 25
Chicago 24
San Francisco 19
Nuremberg 18
Da Nang 17
Haiphong 17
Miano 17
Phoenix 17
São Paulo 17
Vienna 17
Montecorvino Rovella 15
Paris 15
Chandler 14
The Dalles 14
Boydton 13
Atlanta 11
Brooklyn 11
Tokyo 11
Aversa 10
Kochi 10
London 10
Baku 9
Bologna 9
Bremen 9
Charlotte 9
Frankfurt am Main 9
Houston 9
Turin 9
Helsinki 8
Johannesburg 8
Manchester 8
Turku 8
Angers 7
Bari 7
Princeton 7
San José 7
Biên Hòa 6
Brasília 6
Buffalo 6
Castellammare di Stabia 6
Falkenstein 6
Manassas 6
Mexico City 6
Miami 6
Mumbai 6
Stockholm 6
Toronto 6
Warsaw 6
Boston 5
Catania 5
City of London 5
Denver 5
Hyderabad 5
Memphis 5
Montreal 5
Porto Alegre 5
Quito 5
Quảng Ngãi 5
Secaucus 5
Shanghai 5
Belo Horizonte 4
Cambridge 4
Caserta 4
Chennai 4
Curitiba 4
Dormagen 4
Guangzhou 4
Hải Dương 4
Joinville 4
Lappeenranta 4
Nairobi 4
Palermo 4
Philadelphia 4
Roxbury 4
Tashkent 4
Thái Bình 4
Totale 4.426
Nome #
Hericium erinaceus, a medicinal fungus with a centuries-old history: Evidence in gastrointestinal diseases 254
Melanocortin 3,5 receptors immunohistochemical expression in colonic mucosa of inflammatory bowel disease patients: A matter of disease activity? 241
A 60-Year-Old Woman with Primary Biliary Cholangitis and Crohn's Ileitis Following the Suspension of Ursodeoxycholic Acid 193
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 178
EFFICACY OF USTEKINUMAB IN THE TREATMENT OF PATIENTS WITH CROHN’S DISEASE WITH FAILURE TO PREVIOUS CONVENTIONAL OR BIOLOGIC THERAPY: A PROSPECTIVE OBSERVATIONAL REAL-LIFE STUDY 177
BNT162b2 mRNA COVID-19 vaccine is safe in a setting of patients on biologic therapy with inflammatory bowel diseases: a monocentric real-life study 171
A Combination of Microarray-Based Profiling and Biocomputational Analysis Identified miR331-3p and hsa-let-7d-5p as Potential Biomarkers of Ulcerative Colitis Progression to Colorectal Cancer 168
Global treatment of haemorrhoids-A worldwide snapshot audit conducted by the International Society of University Colon and Rectal Surgeons 166
Influence of diabetes mellitus on inflammatory bowel disease course and treatment outcomes. A systematic review with meta-analysis 165
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 161
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 158
Targeting the gut-brain axis for therapeutic adherence in patients with inflammatory bowel disease: a review on the role of psychotherapy 153
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 153
Erectile and sexual dysfunction in male and female patients with celiac disease: A cross-sectional observational study 153
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 149
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials 148
Endoscopic calcium electroporation for unfit-for-surgery bleeding colorectal cancer: the dawn of a new treatment? 147
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review 145
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 144
Hericium erinaceus, in combination with natural flavonoid/alkaloid and B3/B8 vitamins, can improve inflammatory burden in Inflammatory bowel diseases tissue: an ex vivo study 142
Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up 142
Charting new AI education in gastroenterology: Cross-sectional evaluation of ChatGPT and perplexity AI in medical residency exam 141
Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study 140
Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand 139
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis 139
The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey 138
Profiling the patient with inflammatory bowel disease in the relationship between physical activity and partner/social network status: A post hoc patient-tailored analysis of the "BE-FIT-IBD" study 138
Diagnosis and management of caustic ingestion: an interdisciplinary nationwide cross-sectional survey from the Italian society of endoscopic surgery and new technologies (SICE), the Italian society of digestive endoscopy (SIED), the world society of emergency surgery-Italy chapter (WSESit), and the Italian society of surgical endoscopy and digestive diseases (ISSE) 135
Intestinal pseudo-obstruction as systemic lupus erythematosus complication: is it time to reconsider the role of surgery? A case report of a tailored multidisciplinary managed 44-year-old male patient 134
Considering a Janus kinase inhibitor in patients with concomitant ulcerative colitis and hidradenitis suppurativa/acne inversa: is it really a gamble? Hints from a case report 133
Impact of Helicobacter pylori Eradication on Inflammatory Bowel Disease Onset and Disease Activity: To Eradicate or Not to Eradicate? 128
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 127
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 127
Quality of bowel preparation in patients with inflammatory bowel disease undergoing colonoscopy: What factors to consider? 126
Cutaneous Kaposi's Sarcoma Following Long-Term Infliximab Treatment in a Patient with HIV-Negative Antibiotic-Dependent Chronic Pouchitis: Considerations on an Exceptional Finding 125
Editorial: Challenges in Inflammatory Bowel Disease: Current, Future and Unmet Needs 121
Vanek's Tumour as a Rare Cause of Dyspeptic Syndrome in a Patient with Primary Biliary Cholangitis: A Case Report 121
Author's reply: “Assessing ChatGPT and perplexity AI performance” 121
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces 117
A Large Language Model Chatbot Would Only Be as Intelligent as the Mind That Uses It! 116
Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies 116
Clear Cell Renal Carcinoma in an Ulcerative Colitis Patient Under Short-Term Immunosuppressive Therapy: A Case Report 113
Depression weights in patients with gastric cancer: Bibliometric analysis as a weapon to chart the future of research 113
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The "BE-FIT-IBD" study 113
Editorial: Challenges in inflammatory bowel disease: current, future and unmet needs, volume II 112
Advancement of haemostatic self-assembling peptides in the treatment of gastrointestinal bleeding: What role for PuraStat®? 110
Potential of traditional Chinese medicine in gastrointestinal disorders: Hericium erinaceus in chronic atrophic gastritis 109
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future? 108
Therapeutic adherence recorded in the outpatient follow-up of inflammatory bowel diseases in a referral center: Damages of COVID-19 107
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence 104
Irritable bowel syndrome remains a complex disorder of gut-brain interaction: Too many actors on stage 103
Conversational LLM Chatbot ChatGPT-4 for Colonoscopy Boston Bowel Preparation Scoring: An Artificial Intelligence-to-Head Concordance Analysis 103
Enhancing Oral 5-ASA Effectiveness in Mild-to-Moderate Ulcerative Colitis through an H. erinaceus-Based Nutraceutical Add-on Multi-Compound: The “HERICIUM-UC” Two-Arm Multicentre Retrospective Study 102
Emerging space for non-polyethene-glycol bowel preparations in inflammatory bowel disease-related colonoscopy: Veering toward better adherence and palatability 100
Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study 99
Too Many Couch Potatoes Among Middle-Aged Inflammatory Bowel Disease Patients: Findings from the "BE-FIT-IBD-2" Study 91
Water-assisted colonoscopy in inflammatory bowel diseases: From technical implications to diagnostic and therapeutic potentials 90
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study 86
Editorial: Clinical management of Helicobacter pylori infections 84
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study 77
When the vermiform appendix resembles a polyp: Be cautious of an intussuscepted appendix polypectomy 74
Machine learning as a tool predicting short-term postoperative complications in Crohn’s disease patients undergoing intestinal resection: What frontiers? 58
Unravelling the pathogenesis of Eosinophilic Esophagitis from genetic predisposition to environmental triggers 47
Management of Post-Colonoscopy Syndrome with a Nutraceutical Intervention Based on Hericium erinaceus: A Retrospective Two-Arm Multicentre Analysis 26
Relationship between statin use and inflammatory bowel disease: Exploring possible implications 24
Upadacitinib's Effectiveness and Safety as a Second- or Third-Line Therapy in Patients with Ulcerative Colitis: Data from a Real-World Study 23
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD) 23
Very rare isolated colonic inflammatory cap polyps in a patient with known long-standing ulcerative colitis 23
Comparative Effectiveness and Safety of Tofacitinib, Filgotinib, and Upadacitinib in Ulcerative Colitis: A Multicenter Real-World Cohort Study 23
Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study 21
Analysis of possible baseline and treatment-course factors associated with non-remission in patients with Crohn’s disease treated with ustekinumab: a retrospective real-life analysis 21
Relevance of Glucagon-Like Peptide 1 (GLP-1) in Inflammatory Bowel Diseases: A Narrative Review 20
The eternal dichotomy between early biologic therapy and early surgery in Crohn's disease: which should truly take precedence? 19
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora Study 19
Concomitant 5‐Aminosalicylic Acid Does Not Affect the Efficacy of Janus Kinase Inhibitors in Ulcerative Colitis 18
Sex-Specific Real-Life Profiling in Vedolizumab, Ustekinumab, and Tofacitinib Effectiveness in Ulcerative Colitis 18
Work Absenteeism in Inflammatory Bowel Disease Patients Related to Patient-Reported Anxiety Levels and Disease Activity: The IBD-GO-WORK Study 18
Gastric ischemic conditioning before esophagectomy: contemporary practices and insights from an international survey 17
Prudence is never excessive: Caution warranted in 5-aminosalicylic acid derivatives withdrawal for ulcerative colitis 16
Management of Pregnancy in Women with Inflammatory Bowel Disease: Positioning Janus Kinase Inhibitors Within Current Evidence 15
Filgotinib effectiveness and safety as second or third-line therapy in patients with ulcerative colitis: data from a real-world study 15
Endoscopic balloon dilation in pre-pouch ileal strictures in patients with Crohn's-like disease of the pouch - A tool not to be overlooked! 15
Editorial: The emerging role of large language model chatbots in gastroenterology and digestive endoscopy 14
Totale 8.581
Categoria #
all - tutte 27.750
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.750


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202237 0 0 0 0 0 0 6 1 0 3 16 11
2022/2023212 5 3 1 3 64 10 4 8 96 9 6 3
2023/2024367 16 19 23 28 48 56 11 11 4 19 38 94
2024/20251.182 10 14 42 62 174 142 145 108 203 95 82 105
2025/20265.527 257 397 340 248 429 2.689 344 252 146 127 208 90
2026/20271.256 88 196 431 541 0 0 0 0 0 0 0 0
Totale 8.581